Needham & Company Maintains a 'Hold' on ISIS Pharmaceuticals (ISIS); Pipeline Progress Review – Long-Term, Early Stage Programs Are Encouraging

Go back to Needham & Company Maintains a 'Hold' on ISIS Pharmaceuticals (ISIS); Pipeline Progress Review – Long-Term, Early Stage Programs Are Encouraging
GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 52.41 +0.45 (0.87%)
Previous Close $51.96    52 Week High $45.58 
Open $51.35    52 Week Low $37.82 
Day High $52.57    P/E N/A 
Day Low $51.35    EPS $0.00 
Volume 2,404,769       

Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) Delayed: 57.56 --0 (-0%)
Previous Close $57.56    52 Week High $77.80 
Open $3.73    52 Week Low $37.38 
Day High $57.56    P/E N/A 
Day Low $57.56    EPS $-0.35 
Volume 15       

SANOFI (NASDAQ: SNY) Delayed: 45.85 +0.70 (1.55%)
Previous Close $45.15    52 Week High $44.76 
Open $45.26    52 Week Low $36.81 
Day High $46.11    P/E N/A 
Day Low $45.25    EPS $0.00 
Volume 1,860,731